362 related articles for article (PubMed ID: 28286741)
1. Sampling Strategies for Three-Dimensional Spatial Community Structures in IBD Microbiota Research.
Zhang S; Cao X; Huang H
Front Cell Infect Microbiol; 2017; 7():51. PubMed ID: 28286741
[TBL] [Abstract][Full Text] [Related]
2. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
[TBL] [Abstract][Full Text] [Related]
3. Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD.
Casén C; Vebø HC; Sekelja M; Hegge FT; Karlsson MK; Ciemniejewska E; Dzankovic S; Frøyland C; Nestestog R; Engstrand L; Munkholm P; Nielsen OH; Rogler G; Simrén M; Öhman L; Vatn MH; Rudi K
Aliment Pharmacol Ther; 2015 Jul; 42(1):71-83. PubMed ID: 25973666
[TBL] [Abstract][Full Text] [Related]
4. Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease?
Ijssennagger N; van der Meer R; van Mil SWC
Trends Mol Med; 2016 Mar; 22(3):190-199. PubMed ID: 26852376
[TBL] [Abstract][Full Text] [Related]
5. Compositional Changes in the Gut Mucus Microbiota Precede the Onset of Colitis-Induced Inflammation.
Glymenaki M; Singh G; Brass A; Warhurst G; McBain AJ; Else KJ; Cruickshank SM
Inflamm Bowel Dis; 2017 Jun; 23(6):912-922. PubMed ID: 28498157
[TBL] [Abstract][Full Text] [Related]
6. Functional impacts of the intestinal microbiome in the pathogenesis of inflammatory bowel disease.
Li J; Butcher J; Mack D; Stintzi A
Inflamm Bowel Dis; 2015 Jan; 21(1):139-53. PubMed ID: 25248007
[TBL] [Abstract][Full Text] [Related]
7. Site- and Taxa-Specific Disease-Associated Oral Microbial Structures Distinguish Inflammatory Bowel Diseases.
Somineni HK; Weitzner JH; Venkateswaran S; Dodd A; Prince J; Karikaran A; Sauer CG; Abramowicz S; Zwick ME; Cutler DJ; Okou DT; Chopra P; Kugathasan S
Inflamm Bowel Dis; 2021 Nov; 27(12):1889-1900. PubMed ID: 34002220
[TBL] [Abstract][Full Text] [Related]
8. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
[TBL] [Abstract][Full Text] [Related]
9. The fingerprint of the human gastrointestinal tract microbiota: a hypothesis of molecular mapping.
Tomasello G; Mazzola M; Jurjus A; Cappello F; Carini F; Damiani P; Gerges Geagea A; Zeenny MN; Leone A
J Biol Regul Homeost Agents; 2017; 31(1):245-249. PubMed ID: 28337900
[TBL] [Abstract][Full Text] [Related]
10. Recent progress on the role of gut microbiota in the pathogenesis of inflammatory bowel disease.
Yu CG; Huang Q
J Dig Dis; 2013 Oct; 14(10):513-7. PubMed ID: 23848393
[TBL] [Abstract][Full Text] [Related]
11. Dysbiotic events in gut microbiota: impact on human health.
Schippa S; Conte MP
Nutrients; 2014 Dec; 6(12):5786-805. PubMed ID: 25514560
[TBL] [Abstract][Full Text] [Related]
12. Intestinal epithelial glycosylation in homeostasis and gut microbiota interactions in IBD.
Kudelka MR; Stowell SR; Cummings RD; Neish AS
Nat Rev Gastroenterol Hepatol; 2020 Oct; 17(10):597-617. PubMed ID: 32710014
[TBL] [Abstract][Full Text] [Related]
13. Endoscopic Delivery of Fecal Biotherapy in Inflammatory Bowel Disease.
Kerman DH
Gastrointest Endosc Clin N Am; 2016 Oct; 26(4):707-17. PubMed ID: 27633598
[TBL] [Abstract][Full Text] [Related]
14. Dysbiosis in intestinal inflammation: Cause or consequence.
Buttó LF; Haller D
Int J Med Microbiol; 2016 Aug; 306(5):302-309. PubMed ID: 27012594
[TBL] [Abstract][Full Text] [Related]
15. Interrelatedness between dysbiosis in the gut microbiota due to immunodeficiency and disease penetrance of colitis.
Ray A; Dittel BN
Immunology; 2015 Nov; 146(3):359-68. PubMed ID: 26211540
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid and dietary effects on mucosal microbiota in canine inflammatory bowel disease.
Atherly T; Rossi G; White R; Seo YJ; Wang C; Ackermann M; Breuer M; Allenspach K; Mochel JP; Jergens AE
PLoS One; 2019; 14(12):e0226780. PubMed ID: 31887117
[TBL] [Abstract][Full Text] [Related]
17. Microbial Signatures as a Predictive Tool in IBD-Pearls and Pitfalls.
Waldschmitt N; Metwaly A; Fischer S; Haller D
Inflamm Bowel Dis; 2018 May; 24(6):1123-1132. PubMed ID: 29788358
[TBL] [Abstract][Full Text] [Related]
18. Role of intestinal microbiota and metabolites in inflammatory bowel disease.
Dong LN; Wang M; Guo J; Wang JP
Chin Med J (Engl); 2019 Jul; 132(13):1610-1614. PubMed ID: 31090547
[TBL] [Abstract][Full Text] [Related]
19. [The role of gut microbiota dysbiosis in the occurrence and development of inflammatory bowel disease and its prevention and control strategies].
Yang ZY; Li M
Zhonghua Yu Fang Yi Xue Za Zhi; 2022 Sep; 56(9):1175-1181. PubMed ID: 36207877
[TBL] [Abstract][Full Text] [Related]
20. The gut microbiota and inflammatory bowel disease.
Matsuoka K; Kanai T
Semin Immunopathol; 2015 Jan; 37(1):47-55. PubMed ID: 25420450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
